Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.75 USD | +1.43% | +4.68% | +9.50% |
Dec. 18 | Stephens Upgrades Azenta to Overweight From Equal Weight, Adjusts Price Target to $60 From $50 | MT |
Dec. 03 | Dentsply Sirona Names Herman Cueto Interim Finance Chief | MT |
Chart calendar Azenta, Inc.
Upcoming events on Azenta, Inc.
Past events on Azenta, Inc.
2024-11-20 02:00 pm | Stephens Investment Conference |
2024-11-12 04:30 pm | Q4 2024 Earnings Call |
2024-11-12 04:05 pm | Q4 2024 Earnings Release |
2024-09-15 | GENEWIZ Conference |
2024-08-11 | Needham Virtual MedTech & Diagnostics 1x1 Conference |
2024-08-06 04:30 pm | Q3 2024 Earnings Call |
2024-08-06 04:05 pm | Q3 2024 Earnings Release |
2024-06-05 11:00 am | Jefferies Global Healthcare Conference |
2024-05-08 04:30 pm | Q2 2024 Earnings Call |
2024-05-08 04:05 pm | Q2 2024 Earnings Release |
2024-04-08 12:45 pm | Needham Healthcare Conference |
2024-03-19 12:45 pm | KeyBanc Life Sciences & MedTech Forum |
2024-03-14 09:00 am | Investor Day |
2024-02-07 04:30 pm | Q1 2024 Earnings Call |
2024-02-07 04:05 pm | Q1 2024 Earnings Release |
2024-02-05 12:00 pm | Society for Laboratory Automation and Screening International Conference |
2024-01-30 10:00 am | Annual General Meeting |
2024-01-18 10:15 am | Needham Growth Conference |
2024-01-11 10:30 am | JPMorgan Healthcare Conference |
2023-11-28 | Evercore ISI HealthCONx Conference |
Past dividends on Azenta, Inc.
2021-12-01 | Quarterly 0.1 USD |
2021-09-01 | Quarterly 0.1 USD |
2021-06-02 | Quarterly 0.1 USD |
2021-03-03 | Quarterly 0.1 USD |
2020-12-02 | Quarterly 0.1 USD |
2020-09-02 | Quarterly 0.1 USD |
2020-06-03 | Quarterly 0.1 USD |
2020-03-04 | Quarterly 0.1 USD |
2019-12-04 | Quarterly 0.1 USD |
2019-09-04 | Quarterly 0.1 USD |
2019-06-05 | Quarterly 0.1 USD |
2019-02-27 | Quarterly 0.1 USD |
2018-12-05 | Quarterly 0.1 USD |
2018-09-05 | Quarterly 0.1 USD |
2018-05-30 | Quarterly 0.1 USD |
2018-02-28 | Quarterly 0.1 USD |
2017-11-29 | Quarterly 0.1 USD |
2017-09-06 | Quarterly 0.1 USD |
2017-05-30 | Quarterly 0.1 USD |
2017-02-28 | Quarterly 0.1 USD |
Annual results
Fiscal Period | September | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 555 552 0.69% | 665 656 1.44% | 656 661 -0.73% | 596 | 636 | 681 |
EBITDA Million USD | Released Forecast Spread | 62,5 64,3 -2.77% | 30,4 26,8 13.32% | 49,3 49,9 -1.26% | 65,0 | 91,0 | 127 |
EBIT Million USD | Released Forecast Spread | 28,5 25,8 10.28% | -15,3 -22,3 31.52% | -2,90 -8,39 65.51% | 11,9 | 33,6 | 76,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,94 -12,7 21.82% | -30,4 -37,0 17.69% | -167 -164 -2.16% | -23,0 | 19,4 | 56,3 |
Net income Million USD | Released Forecast Spread | 2 133 2 149 -0.76% | -14,3 -27,4 47.93% | -164 -163 -0.75% | -23,1 | 1,59 | 40,5 |
EPS USD | Released Forecast Spread | 28,5 7,03 304.98% | -0,22 -0,40 44.72% | -3,09 -3,05 -1.39% | -0,58 | -0,10 | 0,83 |
Announcement Date | 14/11/22 | 13/11/23 | 12/11/24 | - |
Quarterly results
Fiscal Period | September | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 148 162 -8.34% | 166 153 8.23% | 172 164 5.16% | 154 151 2.09% | 159 160 -0.46% | 173 169 2.55% | 170 170 0.13% | 146 | 142 | 151 | 158 | 155 | 152 | 160 | 167 |
EBITDA Million USD | Released Forecast Spread | -2,40 1,02 -334.91% | 12,9 0,30 4235.07% | 7,94 4,16 91.01% | 4,56 0,40 1047.36% | 9,44 7,26 30.04% | 17,9 12,2 46.69% | 17,4 18,0 -3.25% | 13,6 | 12,6 | 18,6 | 20,4 | 20,7 | 20,7 | 25,3 | 25,6 |
EBIT Million USD | Released Forecast Spread | -13,3 -11,4 -16.42% | -1,06 -12,7 91.67% | -0,90 -7,95 88.73% | -8,71 -12,9 32.43% | -5,74 -6,90 16.85% | 4,58 -1,96 333.44% | 6,97 4,14 68.4% | 0,13 | 0,75 | 4,49 | 6,31 | 7,30 | 7,13 | 11,6 | 12,5 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,25 -18,7 71.98% | -3,67 -21,1 82.64% | -5,64 -12,2 53.7% | -15,9 -14,3 -11.13% | -137 -11,3 -1116.89% | -7,03 -8,04 12.52% | -7,24 -4,19 -72.86% | -8,70 | -8,43 | -1,23 | -0,99 | 1,51 | 1,27 | 7,95 | 8,76 |
Net income Million USD | Released Forecast Spread | -4,93 -14,7 66.54% | -1,47 -12,3 88.04% | 3,38 -10,2 133.05% | -15,7 -11,4 -38.18% | -137 -7,80 -1655.04% | -6,58 -6,85 3.91% | -4,98 -4,26 -17.01% | -5,79 | -7,19 | -2,08 | -0,57 | -0,45 | -0,62 | 4,19 | 4,72 |
EPS USD | Released Forecast Spread | -0,07 -0,22 67.44% | -0,02 -0,15 86.3% | 0,06 -0,17 135.71% | -0,28 -0,21 -35.92% | -2,47 -0,18 -1287.64% | -0,12 -0,12 -3.45% | -0,10 -0,12 13.04% | -0,13 | -0,15 | -0,04 | -0,01 | -0,01 | -0,02 | 0,09 | 0,10 |
Announcement Date | 09/05/23 | 08/08/23 | 13/11/23 | 07/02/24 | 08/05/24 | 06/08/24 | 12/11/24 | - | - | - | - | - | - | - | - |
2025-01-28 | LONZA GROUP AG: Q4 2024 Earnings Release |
2025-02-05 06:30 am | BIO-TECHNE CORPORATION: Q2 2025 Earnings Release |
2025-02-05 04:05 pm | QIAGEN N.V.: Q4 2024 Earnings Release |
2025-02-05 | REPLIMUNE GROUP, INC.: Q3 2025 Earnings Release (Projected) |
2025-02-06 07:00 am | IQVIA HOLDINGS INC.: Q4 2024 Earnings Release |
2025-02-09 | MEDPACE HOLDINGS, INC.: Q4 2024 Earnings Release |
2025-02-10 | AZENTA, INC.: Q1 2025 Earnings Release (Projected) |
2025-02-11 | IMMUNOVANT, INC.: Q3 2025 Earnings Release (Projected) |
2025-02-11 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: Q4 2024 Earnings Release (Projected) |
2025-02-12 04:01 pm | GALAPAGOS NV: Q4 2024 Earnings Release |
Past sector events for Azenta, Inc.
2025-01-22 | SYNGENE INTERNATIONAL LIMITED: Q3 2025 Earnings Release |
2025-01-15 02:00 am | GENUS PLC: Q2 2025 Sales and Revenue Release - Trading Update |
2025-01-10 12:34 am | POLARIS GROUP: December 2024 Sales and Revenue Release |
2024-12-09 03:53 am | POLARIS GROUP: November 2024 Sales and Revenue Release |
2024-11-27 | FORMYCON AG: Q3 2024 Earnings Release |
2024-11-20 07:00 am | SEPTERNA, INC.: Q3 2024 Earnings Release |
2024-11-20 02:00 am | GENUS PLC: Q1 2025 Sales and Revenue Release - Trading Update |
2024-11-14 08:00 am | ARRIVENT BIOPHARMA, INC.: Q3 2024 Earnings Release |
2024-11-14 08:00 am | SILENCE THERAPEUTICS PLC: Q3 2024 Earnings Release |
2024-11-14 02:00 am | BIOARCTIC AB: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AZTA Stock
- Calendar Azenta, Inc.